Latest Breaking News On - Agendia inc - Page 1 : comparemela.com

National Advertising Division Recommends Agendia Modify or Discontinue Certain Claims for MammaPrint and BluePrint Breast Cancer Tests

National Advertising Division Recommends Agendia Modify or Discontinue Certain Claims for MammaPrint and BluePrint Breast Cancer Tests

New yorkUnited statesJennie rosenbergemailAgendia mammaprintGenomic health incNational program advertising divisionNational programsNational advertising divisionSciences corporationAgendia incSee campaignGenomic healthExact sciences corporationProgram national advertising divisionGenomic testsCreated equal

Agendia to Present New Data on 3-Year Outcome of Chemotherapy Treatment in Patients with Early-Stage Breast Cancer at 2024 ASCO

Agendia to Present New Data on 3-Year Outcome of Chemotherapy Treatment in Patients with Early-Stage Breast Cancer at 2024 ASCO
standard-journal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from standard-journal.com Daily Mail and Mail on Sunday newspapers.

United statesBaylor universityNoord hollandWilliam audehTerri clevengerBreast cancer researchAssociation of mammaprintAmerican society of clinical oncologyAgendia incBaylor university medical centerSarah cannon research instituteAmerican societyClinical oncologyJoyceo shaughnessyTexas oncologyPrimary investigator

Clinical Oncology Next Generation Sequencing Market Revenue Report with Forecast to 2031

Clinical Oncology Next Generation Sequencing Market Revenue Report with Forecast to 2031
bignewsnetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bignewsnetwork.com Daily Mail and Mail on Sunday newspapers.

United statesSouth koreaSouth africaUnited kingdomAsia pacificAgendia incThermo fisher scientific incFoundation medicine incPerkin elmer incSee campaignGenetics incParadigm diagnostics incPartek incorporatedAgilent technologies incCaris life sciences japanResearch newswire

Agendia Announces First Patient Enrolled in DEBRA Trial Using MammaPrint®

IRVINE, Calif. & AMSTERDAM (BUSINESS WIRE) Feb 1, 2024

United statesNoord hollandMegan kernanEric brownVito antonucciWilliam audehA division of michigan healthcare professionalsMichigan healthcare professional radiation oncology instituteMichigan health professionals teamAgendia incBreast radiationLow risk mammaprintComprehensive breast careMichigan healthcare professionalsMammaprint low riskRadiation oncologist

Breast cancer test may make bad chemotherapy

<p>Test may underestimate the benefit of chemotherapy for Black women, especially those who are young</p>

University of illinoisUnited statesHsiao ching huangGarth rauscherEmily stoneOana danciuKent hoskinsGenentech rocheHologic incJournal of the national comprehensive cancer networkCancer ignition fundAgendia incSchool of public healthCollege of medicineMerck coUniversity of illinois chicago